Imipenem Cilastatin

IMIVIB

COMPOSITION
Imipenem500MG
Cilastatin500MG
SPECIFICATION
FORMINJECTABLE
PACKING 1’s
PACKING TYPE
MRP1690

DESCRIPTION

Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with cilastatin, a renal dipeptidase inhibitor. [PubChem]

SIDE EFFECTS

N/A

INDICATION

For the treatment of bacterial infections caused by susceptible bacteria.

Important Notice:-  The Database is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.